Skip Navigation



NDT Advance Access published online on March 14, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn085
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/7/2179    most recent
gfn085v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rüster, C.
Right arrow Articles by Wolf, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rüster, C.
Right arrow Articles by Wolf, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes

Christiane Rüster1, Tzvetanka Bondeva1, Sybille Franke1, Martin Förster2 and Gunter Wolf1

1 Klinik für Innere Medizin III 2 Klinik für Innere Medizin I, Friedrich-Schiller-University, Jena, Germany

Correspondence and offprint requests to: Gunter Wolf, Klinik für Innere Medizin III, Friedrich-Schiller-University, Erlanger-Allee 101, D-07740 Jena, Germany. Tel: +49-3641-9324301; Fax: +49-3641-9324302; E-mail: gunter.wolf{at}med.uni-jena.de



  Abstract

Background. Podocyte injury with loss of cells into the urine seems to be an early factor in diabetic nephropathy. Advanced glycation end-products (AGEs) are important mediators of structural and functional renal abnormalities in diabetic nephropathy. We and others have previously described that mice with a deletion in the gene for the cell cycle regulatory p27Kip1 are protected from some features of diabetic nephropathy.

Methods. The present study investigates a potential influence of AGE-modified bovine serum albumin (AGE-BSA) on podocyte growth and p27Kip1 expression in culture. The p27Kip1 expression was measured by western blots and real-time PCR. Cell cycle analysis, cell hypertrophy, proliferation and various markers of apoptosis and necrosis were assessed. The p27Kip expression was inhibited by siRNA or was overexpressed in podocytes with an inducible expression system.

Results. AGE-BSA was actively taken up into the cell as determined by immunohistochemistry, western blots and HPLC. Incubation with AGE-BSA induced in differentiated podocytes, but not in tubular cells, p27Kip1 mRNA and protein expression. This induction was associated with cell cycle arrest of podocytes, cell hypertrophy (as measured by increases in cell size and protein/cell number ratios) and an increase in necrotic, but not apoptotic cells. Inhibition of p27Kip1 expression with siRNA halted the AGE-BSA-mediated cell cycle arrest and hypertrophy, but did not interfere with AGE uptake into podocytes. In contrast, overexpression of p27Kip1 using an inducible expression system stimulated hypertrophy and cell cycle arrest of podocytes.

Conclusion. Our data demonstrate that AGE-BSA-induced hypertrophy and damage of cultured podocytes occurs by a mechanism involving p27Kip1. This effect can contribute to the loss of podocytes in diabetic nephropathy.

Keywords: advanced glycation end-products (AGEs); cell cycle regulation; diabetic nephropathy; podocytes

Received for publication: 29. 8.07
Accepted in revised form: 29. 1.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
G. Wolf, N. Muller, M. Busch, G. Eidner, C. Kloos, W. Hunger-Battefeld, and U. A Muller
Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1896 - 1901.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.